POLIVY i.v. subst sèche 140 mg flac
7680671650020
CH-67165
L01FX14
07.16.1.
Reimbursement limitations:
POLIVY
Lymphome diffus à grandes cellules B (LDGCB) en rechute ou réfractaire, en association avec le …
1 / 3
google
Details
- Product number
- 6716501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- polatuzumabum vedotinum 140 mg, acidum succinicum, natrii hydroxidum corresp. natrium 2.18 mg, saccharum, polysorbatum 20, pro vitro.
Articles (1)
Polivy 140 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
140.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.18 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 9762.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2023
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 67165
- Drug name
- Polivy, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01FX14
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/06/2021
- Authorization expiration date
- 14/06/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- POLIVY i.v. subst sèche 140 mg flac
- Description (DE)
- POLIVY i.v. Trockensub 140 mg Durchstf
- Market launch
- 15/06/2021
- Narcotic (BTM)
- No